The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models. (Q53119067)
Jump to navigation
Jump to search
scientific article published on 22 February 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models. |
scientific article published on 22 February 2013 |
Statements
The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models (English)
Marco Basiricò
Marco Soster
Stefania Bruno
Loretta Gammaitoni
Lorenzo D'Ambrosio
Stefano Ferrari
Marco Alberghini
22 February 2013